Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic LeukemiaB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious diseaseActive, not recruitingPhase 1 / Phase 22026-10-05NCT07134088

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Amgen180
BeOne Medicines76

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Childrens Hospital Of PhiladelphiaPhiladelphiaUnited States18
Kanagawa Childrens Medical CenterYokohami-shiJapan2
Lucile Packard Childrens Hospital StanfordPalo AltoUnited States2
Seattle Childrens HospitalSeattleUnited States5
St Jude Childrens Research HospitalMemphisUnited States6